# Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation

> **NCT05187455** · PHASE4 · UNKNOWN · sponsor: **Guangzhou General Hospital of Guangzhou Military Command** · enrollment: 34 (estimated)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT05187455
- **Lead sponsor:** Guangzhou General Hospital of Guangzhou Military Command
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-05
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2022-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187455, "Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05187455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*